Trial Profile
The Study of New RIC Regimen of BuFlu in Older or Intolerable Patients With Hematologic Malignant Diseases
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2013
Price :
$35
*
At a glance
- Drugs Busulfan (Primary) ; Fludarabine (Primary) ; Cytarabine; Hydroxycarbamide; Semustine
- Indications Haematological malignancies
- Focus Pharmacodynamics
- 24 Apr 2013 New trial record